Delhi/NCR:

Mohali:

Dehradun:

Bathinda:

Mumbai:

Nagpur:

Lucknow:

Bhubaneswar:

To Book an Appointment

Call Us+91 926 888 0303

Metastatic Breast Cancer: New Advances, New Hope

By Dr. Waseem Abbas in Medical Oncology , Cancer Care / Oncology , Breast Cancer

Dec 08 , 2025 | 2 min read

Breast cancer is one of the most common cancers affecting women across the world and in India. With greater awareness, early detection, and better access to treatment, more women are recovering and living healthy lives after breast cancer.

Metastatic Breast Cancer (MBC) occurs when breast cancer spreads beyond the breast to other parts of the body, such as the bones, lungs, liver, or brain. While it may sound concerning, it’s important to know that today this stage is no longer without hope. Continuous advancements in medical science and targeted treatments are helping patients live longer, maintain a good quality of life, and manage their condition effectively. Modern cancer care focuses not just on controlling the disease, but on enabling patients to live confidently and comfortably.

Precision Medicine and Personalised Care

Not all breast cancers are the same. Doctors now divide metastatic breast cancer into three main types based on certain receptors (proteins found on cancer cells):

  • Hormone Receptor-positive (HR+)/HER2-
  • HER2-positive
  • Triple-Negative Breast Cancer (TNBC)

This classification helps doctors decide which treatment will work best for each patient. With genetic and biomarker testing, doctors can identify the cancer’s unique characteristics and choose the most effective treatment, while reducing unnecessary side effects.

Advanced Therapies Bringing New Hope

Modern treatments are now more targeted and personalised. Instead of treating all patients in the same way, therapies are now tailored to the specific type of cancer.

  • For Hormone Receptor-positive (HR+/HER2-) cancers, new targeted drugs are used along with hormonal therapies. These have greatly improved survival and helped overcome treatment resistance, with options like oral SERDs showing promising results.
  • For HER2-positive metastatic breast cancer, the use of antibody-drug conjugates (a combination of antibodies and chemotherapy drugs) has shown remarkable success in controlling the disease.
  • For Triple-Negative Breast Cancer (TNBC), which is generally more aggressive, new immunotherapies and targeted treatments have significantly improved survival. For patients with inherited gene mutations, special therapies are now providing better disease control and longer life expectancy.

Caring Beyond Cancer Control

Treating metastatic breast cancer is not only about controlling the tumour, it’s also about ensuring the patient’s overall well-being. Emotional support, pain management, fatigue reduction, and daily comfort maintenance are all essential components of modern treatment.

That’s why supportive and palliative care play a major role. The aim is to help patients live their lives fully, not just longer, but better.

Conclusion

Research continues to open new frontiers, from immune-based treatments and cancer vaccines to novel biologic therapies. These advancements are expected to make treatments even more effective in the near future.

Metastatic breast cancer care in India is entering a new and hopeful era, one that is focused on personalisation, innovation, and compassion.

This Breast Cancer Awareness Month, let’s remind everyone of the importance of early detection, regular screening, and timely treatment. And most importantly, let’s stand by those who are fighting this disease with courage and determination because with the right care and support, hope truly lives on.